Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Return on Assets: 2022-2025

Historic Return on Assets for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to -0.35%.

  • Axsome Therapeutics' Return on Assets rose 21.00% to -0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.35%, marking a year-over-year increase of 21.00%. This contributed to the annual value of -0.50% for FY2024, which is 2.00% up from last year.
  • Axsome Therapeutics' Return on Assets amounted to -0.35% in Q3 2025, which was up 12.19% from -0.40% recorded in Q2 2025.
  • In the past 5 years, Axsome Therapeutics' Return on Assets registered a high of -0.33% during Q3 2023, and its lowest value of -0.56% during Q2 2024.
  • Moreover, its 3-year median value for Return on Assets was -0.44% (2023), whereas its average is -0.45%.
  • In the last 5 years, Axsome Therapeutics' Return on Assets decreased by 23bps in 2024 and then increased by 21bps in 2025.
  • Over the past 4 years, Axsome Therapeutics' Return on Assets (Quarterly) stood at -0.56% in 2022, then climbed by 16bps to -0.40% in 2023, then decreased by 11bps to -0.51% in 2024, then grew by 21bps to -0.35% in 2025.
  • Its Return on Assets was -0.35% in Q3 2025, compared to -0.40% in Q2 2025 and -0.48% in Q1 2025.